Equetro
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $12,257 | 207 | 207 |
| 2023 | $16,343 | 289 | 289 |
| 2022 | $11,660 | 216 | 216 |
| 2021 | $110,339 | 575 | 202 |
| 2020 | $49,807 | 466 | 194 |
| 2019 | $72,206 | 886 | 291 |
| 2018 | $261,232 | 1,539 | 362 |
| 2017 | $242,106 | 1,939 | 482 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $326,545 | 70 | 42.1% |
| Food and Beverage | $207,739 | 4,152 | 26.8% |
| Consulting Fee | $160,000 | 16 | 20.6% |
| Honoraria | $46,500 | 29 | 6.0% |
| Gift | $35,126 | 1,849 | 4.5% |
| Travel and Lodging | $39.20 | 1 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| "A Phase IV Unequal Randomization Double-Blind Study To Evaluate the Dose Tolerance and Safety of Extended-Release Equetro (carbamazepine) versus Placebo Followed by an Open-Label and Long Term-Maintenance Treatment in Children and Adolescents Aged 10-17 years Diagnosed with Acute Manic or Mixed Bipolar I Disorder" | Validus Pharmaceuticals LLC | $326,545 | 5 |
Top Doctors Receiving Payments for Equetro — Page 5
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , P.A | Physician Assistant | Mckinney, TX | $606.48 | 4 |
| , PMHNP | Psychiatry | Mckinney, TX | $606.48 | 4 |
| , APRN | Psychiatric/Mental Health | Garland, TX | $605.59 | 5 |
| , D.O | Neurology | Saint Louis, MO | $588.08 | 21 |
| , M.D | Psychiatry | Houston, TX | $586.30 | 14 |
| , FPMHNP-BC | Psychiatric/Mental Health | Bedford, TX | $581.52 | 3 |
| , MD | Psychiatry | Avon Lake, OH | $581.38 | 17 |
| , PA-C | Physician Assistant | Clinton Township, MI | $579.49 | 4 |
| , M.D | Psychiatry | Houston, TX | $569.48 | 26 |
| , M.D | Psychiatry | Olivette, MO | $563.70 | 32 |
| , MD | Psychiatry | Tampa, FL | $557.38 | 20 |
| , M.D | Psychiatry | Livonia, MI | $554.81 | 17 |
| , M. D | Psychiatry | Red Bank, NJ | $551.97 | 18 |
| Amado Suarez | — | Brandon, FL | $550.28 | 14 |
| , MD | Psychiatry | Tampa, FL | $537.93 | 52 |
| , M.D | Psychiatry | Saint Louis, MO | $534.99 | 11 |
| , MD | Psychiatry | Troy, MI | $530.28 | 17 |
| , MD | Specialist | Brooklyn, NY | $529.82 | 24 |
| , MD | Psychiatry | Avon Lake, OH | $529.07 | 18 |
| , M.D | Psychiatry | Gwynedd Valley, PA | $526.23 | 15 |
| , MD | Psychiatry | Pontiac, MI | $522.36 | 21 |
| , PA | Medical | Richardson, TX | $521.78 | 4 |
| , MD | Neurology | Marlton, NJ | $518.25 | 14 |
| , M.D | Psychiatry | Sterling Heights, MI | $517.75 | 33 |
| , RN-BSN, PMHNP-BC | Psychiatric/Mental Health | Troy, MI | $515.94 | 4 |
Manufacturing Companies
- Validus Pharmaceuticals LLC $775,950
Product Information
- Type Drug
- Total Payments $775,950
- Total Doctors 1,176
- Transactions 6,117
About Equetro
Equetro is a drug associated with $775,950 in payments to 1,176 healthcare providers, recorded across 6,117 transactions in the CMS Open Payments database. The primary manufacturer is Validus Pharmaceuticals LLC.
Payment data is available from 2017 to 2024. In 2024, $12,257 was paid across 207 transactions to 207 doctors.
The most common payment nature for Equetro is "Unspecified" ($326,545, 42.1% of total).
Equetro is associated with 1 research study, including ""A Phase IV Unequal Randomization Double-Blind Study To Evaluate the Dose Tolerance and Safety of Extended-Release Equetro (carbamazepine) versus Placebo Followed by an Open-Label and Long Term-Maintenance Treatment in Children and Adolescents Aged 10-17 years Diagnosed with Acute Manic or Mixed Bipolar I Disorder"" ($326,545).